We demonstrated that FRDA patient fibroblasts were more susceptible to iron-dependent Fxn degradation and that inhibiting the Lon protease protected mammalian mitochondrial Fxn from ROS-induced degradation. The gene discussed is FXN; the disease is Friedreich ataxia.